Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Highly Improved Ph-Responsive Anticancer Drug Delivery and T2-Weighted Mri Imaging by Magnetic Mof Cubtc-Based Nano/Microcomposite Publisher



Gharehdaghi Z1 ; Naghib SM2 ; Rahimi R1 ; Bakhshi A3 ; Kefayat A3 ; Shamaeizadeh A2 ; Molaabasi F3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Chemistry, Iran University of Science and Technology, Tehran, Iran
  2. 2. Nanotechnology Department, School of Advanced Technologies, Iran University of Science and Technology (IUST), Tehran, Iran
  3. 3. Biomaterials and Tissue Engineering Research Group, Department of Interdisciplinary Technologies, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran

Source: Frontiers in Molecular Biosciences Published:2023


Abstract

Cu-BTC framework has received a considerable attention in recent years as a drug carrier candidate for cancer treatment due to its unique structural properties and promising biocompatibility. However, its intrinsic deficiency for medical imaging potentially limits its bioapplications; To address this subject, a magnetic nano/microscale MOF has been successfully fabricated by introducing Fe3O4 nanoparticles as an imaging agent into the porous isoreticular MOF [Cu3(BTC)2] as a drug carrier. The synthesized magnetic MOFs exhibits a high loading capacity (40.5%) toward the model anticancer DOX with an excellent pH-responsive drug release. The proposed nanocomposite not only possesses large surface area, high magnetic response, large mesopore volume, high transverse relaxivity (r2) and good stability but also exhibits superior biocompatibility, specific tumor cellular uptake, and significant cancer cell viability inhibitory effect without any targeting agent. It is expected that the synthesized magnetic nano/microcomposite may be used for clinical purposes and can also serve as a platform for photoactive antibacterial therapy ae well as pH/GSH/photo-triple-responsive nanocarrier. Copyright © 2023 Gharehdaghi, Naghib, Rahimi, Bakhshi, Kefayat, shamaeizadeh and Molaabasi.
Other Related Docs